Apixaban

CAS 503612-47-3 52 API suppliersSmall Molecule

Overview

Apixaban is an oral anticoagulant medication that works by inhibiting factor Xa, an important component in the blood coagulation pathway. It is commonly used to prevent and treat blood clots and reduce the risk of stroke in patients with atrial fibrillation.

API suppliers (52)

Suppliers of Apixaban evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India30China8Pakistan1Canada1Taiwan1Malta1Netherlands1USA1

Country recorded for 44 of 52 suppliers.

25 of 52 hold a GMP certificate on record in the EU or UK registers

Showing 25 of 52 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (8 approved US products), the latest listed US patent on Apixaban expires 22 May 2041 and exclusivity 17 Oct 2028. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

CardiovascularHematology
Verified Supplier Partner

Do you supply Apixaban? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.